{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:58:53Z","timestamp":1792699133833,"version":"4.5.0"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004386","name":"Universiti Malaya","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03387-6","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:32:31Z","timestamp":1774391551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Microneedle-Assisted Delivery of Biologics: From Large Molecules to Cancer Vaccines"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9649-6820","authenticated-orcid":false,"given":"Salma","family":"Younas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1603-9295","authenticated-orcid":false,"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9373-0443","authenticated-orcid":false,"given":"Ramsha","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0147-7779","authenticated-orcid":false,"given":"Kirthana","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6715-638X","authenticated-orcid":false,"given":"Akshay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-2431","authenticated-orcid":false,"given":"Pornanong","family":"Aramwit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9052-147X","authenticated-orcid":false,"given":"Syed","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"3387_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010277","volume":"15","author":"HX Nguyen","year":"2023","unstructured":"Nguyen HX, Nguyen CN. Microneedle-mediated transdermal delivery of biopharmaceuticals. Pharmaceutics. 2023;15: 277. https:\/\/doi.org\/10.3390\/pharmaceutics15010277.","journal-title":"Pharmaceutics"},{"key":"3387_CR2","unstructured":"Center for Drug Evaluation and Research. Frequently asked questions about therapeutic biological products. FDA.; 2019. https:\/\/www.fda.gov\/drugs\/therapeutic-biologics-applications-bla\/frequently-asked-questions-about-therapeutic-biological-products. Accessed 10 Oct 2025."},{"key":"3387_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrd4363","volume":"13","author":"S Mitragotri","year":"2014","unstructured":"Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014;13:655\u201372. https:\/\/doi.org\/10.1038\/nrd4363.","journal-title":"Nat Rev Drug Discov"},{"key":"3387_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02844-6","author":"M Kirkby","year":"2020","unstructured":"Kirkby M, Hutton ARJ, Donnelly RF. Microneedle mediated transdermal delivery of protein, peptide and antibody based therapeutics: current status and future considerations. Pharm Res. 2020. https:\/\/doi.org\/10.1007\/s11095-020-02844-6.","journal-title":"Pharm Res"},{"key":"3387_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/21691401.2018.1430695","volume":"46","author":"B Chaulagain","year":"2018","unstructured":"Chaulagain B, Jain A, Tiwari A, Verma A, Jain SK. Passive delivery of protein drugs through transdermal route. Artif Cells Nanomed Biotechnol. 2018;46:472\u201387. https:\/\/doi.org\/10.1080\/21691401.2018.1430695.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3387_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020190","volume":"15","author":"F Damiri","year":"2022","unstructured":"Damiri F, Kommineni N, Ebhodaghe SO, Bulusu R, Jyothi VGSS, Sayed AA, Awaji AA, Germoush MO, Al-malky HS, Nasrullah MZ, Rahman MH, Abdel-Daim MM, Berrada M. Microneedle-based natural polysaccharide for drug delivery systems (DDS): progress and challenges. Pharmaceuticals. 2022;15: 190. https:\/\/doi.org\/10.3390\/ph15020190.","journal-title":"Pharmaceuticals"},{"key":"3387_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/03639045.2018.1539497","volume":"45","author":"S Dharadhar","year":"2018","unstructured":"Dharadhar S, Majumdar A, Dhoble S, Patravale V. Microneedles for transdermal drug delivery: a systematic review. Drug Dev Ind Pharm. 2018;45:188\u2013201. https:\/\/doi.org\/10.1080\/03639045.2018.1539497.","journal-title":"Drug Dev Ind Pharm"},{"key":"3387_CR8","doi-asserted-by":"publisher","first-page":"111786","DOI":"10.1016\/j.msec.2020.111786","volume":"120","author":"AD Permana","year":"2021","unstructured":"Permana AD, Anjani QK, Utomo E, Volpe-Zanutto F, Paredes AJ, Evary YM, Mardikasari SA, Pratama MR, Tuany IN, Donnelly RF. Selective delivery of silver nanoparticles for improved treatment of biofilm skin infection using bacteria-responsive microparticles loaded into dissolving microneedles. Mater Sci Eng C. 2021;120:111786. https:\/\/doi.org\/10.1016\/j.msec.2020.111786.","journal-title":"Mater Sci Eng C"},{"key":"3387_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102595118","volume":"118","author":"C Caudill","year":"2021","unstructured":"Caudill C, Perry JL, Iliadis K, Tessema AT, Lee BJ, Mecham BS, Tian S, DeSimone JM. Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity. Proc Natl Acad Sci U S A. 2021;118: e2102595118. https:\/\/doi.org\/10.1073\/pnas.2102595118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3387_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/mi12020117","volume":"12","author":"S Economidou","year":"2021","unstructured":"Economidou S, Pissinato Pere C, Okereke M, Douroumis D. Optimisation of design and manufacturing parameters of 3D printed solid microneedles for improved strength, sharpness, and drug delivery. Micromachines. 2021;12: 117. https:\/\/doi.org\/10.3390\/mi12020117.","journal-title":"Micromachines"},{"key":"3387_CR11","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/acs.molpharmaceut.2c00466","volume":"19","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wu H, Zhao SG, Chen X, Wei T, Peng H, Chen Z. 3D-printed integrated ultrasonic microneedle array for rapid transdermal drug delivery. Mol Pharm. 2022;19:3314\u201322. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00466.","journal-title":"Mol Pharm"},{"key":"3387_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.7150\/thno.61747","volume":"12","author":"G Chen","year":"2022","unstructured":"Chen G, Kang W, Li W, Chen S, Gao Y. Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies. Theranostics. 2022;12:1419\u201339. https:\/\/doi.org\/10.7150\/thno.61747.","journal-title":"Theranostics"},{"key":"3387_CR13","doi-asserted-by":"publisher","unstructured":"Bolge S, Goren A, Tandon N. Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective. Patient Prefer Adherence. 2015;121. https:\/\/doi.org\/10.2147\/ppa.s70834.","DOI":"10.2147\/ppa.s70834"},{"key":"3387_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115301","author":"N Mathias","year":"2024","unstructured":"Mathias N, Huille S, Picci M, Mahoney RP, Pettis RJ, Case B, Helk B, Kang D, Shah R, Ma J, Bhattacharya D, Krishnamachari Y, Doucet D, Maksimovikj N, Babaee S, Garidel P, Esfandiary R, Gandhi R. Towards more tolerable subcutaneous administration: review of contributing factors for improving combination product design. Adv Drug Deliv Rev. 2024. https:\/\/doi.org\/10.1016\/j.addr.2024.115301.","journal-title":"Adv Drug Deliv Rev"},{"key":"3387_CR15","doi-asserted-by":"publisher","unstructured":"Zhi L, Liu D, Shameem M. Injection site reactions of biologics and mitigation strategies. AAPS Open. 2025;11(1):5.  https:\/\/doi.org\/10.1186\/s41120-025-00108-4","DOI":"10.1186\/s41120-025-00108-4"},{"key":"3387_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/archderm.137.7.893","volume":"137","author":"R Zeltser","year":"2001","unstructured":"Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin C, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor \u03b1 receptor: Fc fusion protein. Arch Dermatol. 2001;137:893\u20139. https:\/\/doi.org\/10.1001\/archderm.137.7.893.","journal-title":"Arch Dermatol"},{"key":"3387_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2147\/ppa.s187120","volume":"13","author":"DL Gandell","year":"2019","unstructured":"Gandell DL, Bienen EJ, Gudeman J. Mode of injection and treatment adherence: results of a survey characterizing the perspectives of health care providers and US women 18\u201345 years old. Patient Prefer Adher. 2019;13:351\u201361. https:\/\/doi.org\/10.2147\/ppa.s187120.","journal-title":"Patient Prefer Adher"},{"key":"3387_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12817","volume":"32","author":"E Thomaidou","year":"2019","unstructured":"Thomaidou E, Ramot Y. Injection site reactions with the use of biological agents. Dermatol Ther. 2019;32: e12817. https:\/\/doi.org\/10.1111\/dth.12817.","journal-title":"Dermatol Ther"},{"key":"3387_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28207165","volume":"28","author":"G Rossino","year":"2023","unstructured":"Rossino G, Marchese E, Galli G, Verde F, Finizio M, Serra M, Linciano P, Collina S. Peptides as therapeutic agents: challenges and opportunities in the green transition era. Molecules. 2023;28: 7165. https:\/\/doi.org\/10.3390\/molecules28207165.","journal-title":"Molecules"},{"key":"3387_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/193229681200600403","volume":"6","author":"E McVey","year":"2012","unstructured":"McVey E, Hirsch L, Sutter DE, Kapitza C, Dellweg S, Clair J, Rebrin K, Judge K, Pettis RJ. Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion. J Diabetes Sci Technol. 2012;6:743\u201354. https:\/\/doi.org\/10.1177\/193229681200600403.","journal-title":"J Diabetes Sci Technol"},{"key":"3387_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11095-010-0192-9","volume":"28","author":"PE Daddona","year":"2010","unstructured":"Daddona PE, Matriano JA, Mandema J, Maa Y-F. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res. 2010;28:159\u201365. https:\/\/doi.org\/10.1007\/s11095-010-0192-9.","journal-title":"Pharm Res"},{"key":"3387_CR22","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1007\/s11095-009-9960-9","volume":"26","author":"M Ameri","year":"2009","unstructured":"Ameri M, Daddona PE, Maa Y-F. Demonstrated solid-state stability of parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system. Pharm Res. 2009;26:2454\u201363. https:\/\/doi.org\/10.1007\/s11095-009-9960-9.","journal-title":"Pharm Res"},{"key":"3387_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","volume":"161","author":"K van der Maaden","year":"2012","unstructured":"van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release. 2012;161:645\u201355. https:\/\/doi.org\/10.1016\/j.jconrel.2012.01.042.","journal-title":"J Control Release"},{"key":"3387_CR24","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","volume":"64","author":"Y-C Kim","year":"2012","unstructured":"Kim Y-C, Park J-H, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64:1547\u201368. https:\/\/doi.org\/10.1016\/j.addr.2012.04.005.","journal-title":"Adv Drug Deliv Rev"},{"key":"3387_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082029","volume":"15","author":"R Khalid","year":"2023","unstructured":"Khalid R, Mahmood S, Sofian ZM, Hilles AR, Hashim NM, Ge Y. Microneedles and their application in transdermal delivery of antihypertensive drugs\u2014a review. Pharmaceutics. 2023;15: 2029. https:\/\/doi.org\/10.3390\/pharmaceutics15082029.","journal-title":"Pharmaceutics"},{"key":"3387_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119673","volume":"587","author":"KAS AL-Japairai","year":"2020","unstructured":"AL-Japairai KAS, Mahmood S, Almurisi SH, Venugopal JR, Hilles AR, Azmana M, Raman S. Current trends in polymer microneedle for transdermal drug delivery. Int J Pharm. 2020;587: 119673. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119673.","journal-title":"Int J Pharm"},{"key":"3387_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/polym13162815","volume":"13","author":"FK Aldawood","year":"2021","unstructured":"Aldawood FK, Andar A, Desai S. A comprehensive review of microneedles: types, materials, processes, characterizations and applications. Polymers. 2021;13: 2815. https:\/\/doi.org\/10.3390\/polym13162815.","journal-title":"Polymers"},{"key":"3387_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","volume":"348","author":"Z Sartawi","year":"2022","unstructured":"Sartawi Z, Blackshields C, Faisal W. Dissolving microneedles: applications and growing therapeutic potential. J Control Release. 2022;348:186\u2013205. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.045.","journal-title":"J Control Release"},{"key":"3387_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/macromol4020019","volume":"4","author":"C Oliveira","year":"2024","unstructured":"Oliveira C, Teixeira JA, Oliveira N, Ferreira S, Botelho CM. Microneedles\u2019 device: design, fabrication, and applications. Macromol. 2024;4:320\u201355. https:\/\/doi.org\/10.3390\/macromol4020019.","journal-title":"Macromol"},{"key":"3387_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101754","volume":"32","author":"J Kim","year":"2025","unstructured":"Kim J, Jeong J, Jo JK, So H. Hollow microneedles as a flexible dosing control solution for transdermal drug delivery. Mater Today Bio. 2025;32: 101754. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101754.","journal-title":"Mater Today Bio"},{"key":"3387_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120455","volume":"599","author":"\u00c1 C\u00e1rcamo-Mart\u00ednez","year":"2021","unstructured":"C\u00e1rcamo-Mart\u00ednez \u00c1, Mallon B, Dom\u00ednguez-Robles J, Vora LK, Anjani QK, Donnelly RF. Hollow microneedles: a perspective in biomedical applications. Int J Pharm. 2021;599: 120455. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120455.","journal-title":"Int J Pharm"},{"key":"3387_CR32","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.3390\/molecules28217411","volume":"28","author":"Z Qi","year":"2023","unstructured":"Qi Z, Yan Z, Tan G, Kundu SC, Lu S. Smart responsive microneedles for controlled drug delivery. Molecules. 2023;28:7411\u20137411. https:\/\/doi.org\/10.3390\/molecules28217411.","journal-title":"Molecules"},{"key":"3387_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101321","volume":"29","author":"M Liu","year":"2024","unstructured":"Liu M, Jiang J, Wang Y, Liu H, Lu Y, Wang X. Smart drug delivery and responsive microneedles for wound healing. Mater Today Bio. 2024;29: 101321. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101321.","journal-title":"Mater Today Bio"},{"key":"3387_CR34","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","volume":"109","author":"T Waghule","year":"2019","unstructured":"Waghule T, Singhvi G, Dubey SK, Pandey MM, Gupta G, Singh M, Dua K. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. 2019;109:1249\u201358. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.078.","journal-title":"Biomed Pharmacother"},{"key":"3387_CR35","doi-asserted-by":"publisher","unstructured":"Li J, Zeng M, Shan H, Tong C. Microneedle patches as drug and vaccine delivery platform. Curr Med Chem. 2017;24. https:\/\/doi.org\/10.2174\/0929867324666170526124053.","DOI":"10.2174\/0929867324666170526124053"},{"key":"3387_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195912","volume":"26","author":"J Xu","year":"2021","unstructured":"Xu J, Xu D, Xuan X, He H. Advances of microneedles in biomedical applications. Molecules. 2021;26: 5912. https:\/\/doi.org\/10.3390\/molecules26195912.","journal-title":"Molecules"},{"key":"3387_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113302","volume":"226","author":"R Zhang","year":"2023","unstructured":"Zhang R, Miao Q, Deng D, Wu J, Miao Y, Li Y. Research progress of advanced microneedle drug delivery system and its application in biomedicine. Colloids Surf B. 2023;226: 113302. https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113302.","journal-title":"Colloids Surf B"},{"key":"3387_CR38","doi-asserted-by":"publisher","unstructured":"Parhi R. Recent advances in 3D printed microneedles and their skin delivery application in the treatment of various diseases. J Drug Deliv Sci Technol 2023;84:104395.  https:\/\/doi.org\/10.1016\/j.jddst.2023.104395.","DOI":"10.1016\/j.jddst.2023.104395"},{"key":"3387_CR39","doi-asserted-by":"publisher","unstructured":"Parhi R. A review of three-dimensional printing for pharmaceutical applications: quality control, risk assessment and future perspectives. J Drug Deliv Sci Technol. 2021;102571. https:\/\/doi.org\/10.1016\/j.jddst.2021.102571.","DOI":"10.1016\/j.jddst.2021.102571"},{"key":"3387_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120301","volume":"597","author":"N Elahpour","year":"2021","unstructured":"Elahpour N, Pahlevanzadeh F, Kharaziha M, Bakhsheshi-Rad HR, Ramakrishna S, Berto F. 3D printed microneedles for transdermal drug delivery: a brief review of two decades. Int J Pharm. 2021;597: 120301. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120301.","journal-title":"Int J Pharm"},{"key":"3387_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jconrel.2009.05.031","volume":"139","author":"H Chen","year":"2009","unstructured":"Chen H, Zhu H, Zheng J, Mou D, Wan J, Zhang J, Shi T, Zhao Y, Xu H, Yang X. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release. 2009;139:63\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2009.05.031.","journal-title":"J Control Release"},{"key":"3387_CR42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.matt.2021.11.021","volume":"5","author":"P Makvandi","year":"2022","unstructured":"Makvandi P, Maleki A, Shabani M, Hutton ARJ, Kirkby M, Jamaledin R, Fang T, He J, Lee J, Mazzolai B, Donnelly RF, Tay FR, Chen G, Mattoli V. Bioinspired microneedle patches: biomimetic designs, fabrication, and biomedical applications. Matter. 2022;5:390\u2013429. https:\/\/doi.org\/10.1016\/j.matt.2021.11.021.","journal-title":"Matter"},{"key":"3387_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12060569","volume":"12","author":"AJ Guillot","year":"2020","unstructured":"Guillot AJ, Cordeiro AS, Donnelly RF, Montesinos MC, Garrigues TM, Melero A. Microneedle-based delivery: an overview of current applications and trends. Pharmaceutics. 2020;12: 569. https:\/\/doi.org\/10.3390\/pharmaceutics12060569.","journal-title":"Pharmaceutics"},{"key":"3387_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2025.110908","volume":"36","author":"Y Sun","year":"2025","unstructured":"Sun Y, Chen M, Chen Y, Zhao W, Fu Y, Huang Z, Lu C, Wu C, Pan X, Quan G. Dissolving microneedle-assisted in situ cancer vaccine combined with cytolytic peptide for anti-melanoma immunotherapy. Chin Chem Lett. 2025;36: 110908. https:\/\/doi.org\/10.1016\/j.cclet.2025.110908.","journal-title":"Chin Chem Lett"},{"key":"3387_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.msec.2017.12.006","volume":"85","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Jiang G, Yu W, Liu D, Xu B. Microneedles fabricated from alginate and maltose for transdermal delivery of insulin on diabetic rats. Mater Sci Eng C. 2018;85:18\u201326. https:\/\/doi.org\/10.1016\/j.msec.2017.12.006.","journal-title":"Mater Sci Eng C"},{"key":"3387_CR46","doi-asserted-by":"publisher","unstructured":"Oh SJ, Jung JH. Sustainable drug release using nanoparticle encapsulated microneedles. Chem-An Asian J. 2022;17(16):e202200333.\u00a0https:\/\/doi.org\/10.1002\/asia.202200333.","DOI":"10.1002\/asia.202200333"},{"key":"3387_CR47","doi-asserted-by":"publisher","unstructured":"Zhao L., Akmal, McGuckin MB, Li L, Wang Z, Larra\u00f1eta E, Donnelly RF. Implantable microarray patch: engineering at the nano and macro scale for sustained therapeutic release via synthetic biodegradable polymers. Adv Mater Technol. 2024;10. https:\/\/doi.org\/10.1002\/admt.202400346.","DOI":"10.1002\/admt.202400346"},{"key":"3387_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.106040","volume":"167","author":"M Rabiei","year":"2021","unstructured":"Rabiei M, Kashanian S, Bahrami G, Derakhshankhah H, Barzegari E, Samavati SS, McInnes SJP. Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity. Eur J Pharm Sci. 2021;167: 106040. https:\/\/doi.org\/10.1016\/j.ejps.2021.106040.","journal-title":"Eur J Pharm Sci"},{"key":"3387_CR49","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jconrel.2021.08.012","volume":"337","author":"Y Lee","year":"2021","unstructured":"Lee Y, Li W, Tang J, Schwendeman SP, Prausnitz MR. Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin. J Control Release. 2021;337:676\u201385. https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.012.","journal-title":"J Control Release"},{"key":"3387_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-021-09586-x","author":"N Tariq","year":"2021","unstructured":"Tariq N, Ashraf MW, Tayyaba S. A review on solid microneedles for biomedical applications. J Pharm Innov. 2021. https:\/\/doi.org\/10.1007\/s12247-021-09586-x.","journal-title":"J Pharm Innov"},{"key":"3387_CR51","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/pharmaceutics7040486","volume":"7","author":"R Haj-Ahmad","year":"2015","unstructured":"Haj-Ahmad R, Khan H, Arshad M, Rasekh M, Hussain A, Walsh S, Li X, Chang M-W, Ahmad Z. Microneedle coating techniques for transdermal drug delivery. Pharmaceutics. 2015;7:486\u2013502. https:\/\/doi.org\/10.3390\/pharmaceutics7040486.","journal-title":"Pharmaceutics"},{"key":"3387_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jconrel.2017.03.383","volume":"265","author":"Y Chen","year":"2017","unstructured":"Chen Y, Chen BZ, Wang QL, Jin X, Guo XD. Fabrication of coated polymer microneedles for transdermal drug delivery. J Control Release. 2017;265:14\u201321. https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.383.","journal-title":"J Control Release"},{"key":"3387_CR53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1124\/jpet.119.258707","volume":"370","author":"RSJ Ingrole","year":"2019","unstructured":"Ingrole RSJ, Gill HS. Microneedle coating methods: a review with a perspective. J Pharmacol Exp Ther. 2019;370:555\u201369. https:\/\/doi.org\/10.1124\/jpet.119.258707.","journal-title":"J Pharmacol Exp Ther"},{"key":"3387_CR54","doi-asserted-by":"publisher","unstructured":"Kapoor Y, Milewski M, Dick L, Zhang J, Bothe JR, Gehrt M, Manser K, Nissley B, Petrescu I, Johnson P, Burton S, Moseman J, Hua V, Grunewald T, Tomai M, Smith R. Coated microneedles for transdermal delivery of a potent pharmaceutical peptide. Biomed Microdevices. 2019;22. https:\/\/doi.org\/10.1007\/s10544-019-0462-1.","DOI":"10.1007\/s10544-019-0462-1"},{"key":"3387_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110248","volume":"107","author":"MJ Uddin","year":"2020","unstructured":"Uddin MJ, Scoutaris N, Economidou SN, Giraud C, Chowdhry BZ, Donnelly RF, Douroumis D. 3D printed microneedles for anticancer therapy of skin tumours. Mater Sci Eng C. 2020;107: 110248. https:\/\/doi.org\/10.1016\/j.msec.2019.110248.","journal-title":"Mater Sci Eng C"},{"key":"3387_CR56","doi-asserted-by":"publisher","unstructured":"Sonetha V, Majumdar S, Shah S. Step-wise micro-fabrication techniques of microneedle arrays with applications in transdermal drug delivery \u2013 a review. J Drug Deliv Sci Technol. 2022;103119. https:\/\/doi.org\/10.1016\/j.jddst.2022.103119.","DOI":"10.1016\/j.jddst.2022.103119"},{"key":"3387_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/pharmaceutics7030090","volume":"7","author":"K Ita","year":"2015","unstructured":"Ita K. Transdermal delivery of drugs with microneedles\u2014potential and challenges. Pharmaceutics. 2015;7:90\u2013105. https:\/\/doi.org\/10.3390\/pharmaceutics7030090.","journal-title":"Pharmaceutics"},{"key":"3387_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00383-016-4037-4","volume":"33","author":"L Zhao","year":"2016","unstructured":"Zhao L, Mu J, Du P, Wang H, Mao Y, Xu Y, Xin X, Zang F. Ultrasound-guided core needle biopsy in the diagnosis of neuroblastic tumors in children: a retrospective study on 83 cases. Pediatr Surg Int. 2016;33:347\u201353. https:\/\/doi.org\/10.1007\/s00383-016-4037-4.","journal-title":"Pediatr Surg Int"},{"key":"3387_CR59","doi-asserted-by":"crossref","unstructured":"Ramvikas M, Arumugam M, Chakrabarti SR, Jaganathan KS. Nasal vaccine delivery (Chapter fifteen). In: Micro- and nanotechnology in vaccine development; Elsevier Inc.: Amsterdam, The Netherlands; 2017. pp. 279\u2013301.","DOI":"10.1016\/B978-0-323-39981-4.00015-4"},{"key":"3387_CR60","unstructured":"Xenikakis, K. Tsongas, E. Tzimtzimis, O. Katsamenis, D. Tzetzis, D. Fatouros, C. Zacharis, C. Georgiou, E. Tzetzis, D. Transdermal, Materials and Methods 3D Printed hollow microneedles for transdermal insulin delivery, (n.d). https:\/\/eprints.soton.ac.uk\/456154\/2\/PBP2022_poster_Skin_Microneedles_Xenikakis_et_al.pdf,\u00a0Accessed 17 Nov 2025."},{"key":"3387_CR61","doi-asserted-by":"publisher","unstructured":"Abd-El-Azim H, Tekko IA, Ali A, Ramadan A, Nafee N, Khalafallah N, Rahman T, Mcdaid W, Aly RG, Vora LK, Bell SJ. Hollow microneedle assisted intradermal delivery of hypericin lipid nanocapsules with light enabled photodynamic therapy against skin cancer. J Control Release. 2022;348:849-869. https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.027.","DOI":"10.1016\/j.jconrel.2022.06.027"},{"key":"3387_CR62","doi-asserted-by":"publisher","unstructured":"Chu H, Xue J, Yang Y, Zheng H, Luo D, Li Z. Advances of smart stimulus\u2010responsive microneedles in Cancer treatment, small methods. 8 (2023). https:\/\/doi.org\/10.1002\/smtd.202301455.","DOI":"10.1002\/smtd.202301455"},{"key":"3387_CR63","doi-asserted-by":"publisher","first-page":"8956","DOI":"10.1021\/acsnano.6b04989","volume":"10","author":"Y Ye","year":"2016","unstructured":"Ye Y, Wang J, Hu Q, Hochu GM, Xin H, Wang C, Gu Z. Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors. ACS Nano. 2016;10:8956\u201363. https:\/\/doi.org\/10.1021\/acsnano.6b04989.","journal-title":"ACS Nano"},{"key":"3387_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202300014","author":"K Xu","year":"2023","unstructured":"Xu K, Weng J, Li J, Chen X. Advances in intelligent stimuli\u2010responsive microneedle for biomedical applications. Macromol Biosci. 2023. https:\/\/doi.org\/10.1002\/mabi.202300014.","journal-title":"Macromol Biosci"},{"key":"3387_CR65","doi-asserted-by":"publisher","unstructured":"Asha AB, Srinivas S, Hao X, Narain R. Enzyme-responsive polymers: classifications, properties, synthesis strategies, and applications, Elsevier EBooks. 2019;155\u2013189. https:\/\/doi.org\/10.1016\/b978-0-08-102416-4.00005-3.","DOI":"10.1016\/b978-0-08-102416-4.00005-3"},{"key":"3387_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/gels8070454","volume":"8","author":"MJ Ansari","year":"2022","unstructured":"Ansari MJ, Rajendran RR, Mohanto S, Agarwal U, Panda K, Dhotre K, Manne R, Deepak A, Zafar A, Yasir M, Pramanik S. Poly(N-isopropylacrylamide)-based hydrogels for biomedical applications: a review of the state-of-the-art. Gels. 2022;8: 454. https:\/\/doi.org\/10.3390\/gels8070454.","journal-title":"Gels"},{"key":"3387_CR67","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.actbio.2022.08.061","volume":"153","author":"JY Li","year":"2022","unstructured":"Li JY, Feng YH, He YT, Hu LF, Liang L, Zhao ZQ, Chen BZ, Guo XD. Thermosensitive hydrogel microneedles for controlled transdermal drug delivery. Acta Biomater. 2022;153:308\u201319. https:\/\/doi.org\/10.1016\/j.actbio.2022.08.061.","journal-title":"Acta Biomater"},{"key":"3387_CR68","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bioactmat.2020.04.002","volume":"5","author":"Y Hao","year":"2020","unstructured":"Hao Y, Chen Y, He X, Yang F, Han R, Yang C, Li W, Qian Z. Near-infrared responsive 5-fluorouracil and indocyanine green loaded MPEG-PCL nanoparticle integrated with dissolvable microneedle for skin cancer therapy. Bioact Mater. 2020;5:542\u201352. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.04.002.","journal-title":"Bioact Mater"},{"key":"3387_CR69","doi-asserted-by":"publisher","first-page":"103668","DOI":"10.1016\/j.jddst.2022.103668","volume":"75","author":"MK Alshammari","year":"2022","unstructured":"Alshammari MK, Ghazwani JA, Alsharari FO, Alotaibi SS, Alotaibi RM, Alsayahani AA, Alosaimi RB, Alotaibi AN, Imran M, Arshad MF. An update on microneedle in insulin delivery: quality attributes, clinical status and challenges for clinical translation. J Drug Deliv Sci Technol. 2022;75:103668. https:\/\/doi.org\/10.1016\/j.jddst.2022.103668.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3387_CR70","doi-asserted-by":"publisher","first-page":"51934","DOI":"10.1039\/C5RA04340A","volume":"5","author":"R Justin","year":"2015","unstructured":"Justin R, Rom\u00e1n S, Chen D, Tao K, Geng X, Grant RT, MacNeil S, Sun K, Chen B. Biodegradable and conductive chitosan\u2013graphene quantum dot nanocomposite microneedles for delivery of both small and large molecular weight therapeutics. RSC Adv. 2015;5:51934\u201346. https:\/\/doi.org\/10.1039\/C5RA04340A.","journal-title":"RSC Adv"},{"key":"3387_CR71","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jconrel.2018.08.042","volume":"288","author":"X Chen","year":"2018","unstructured":"Chen X, Wang L, Yu H, Li C, Feng J, Haq F, Khan A, Khan RU. Preparation, properties and challenges of the microneedles-based insulin delivery system. J Control Release. 2018;288:173\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2018.08.042.","journal-title":"J Control Release"},{"key":"3387_CR72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.addr.2018.03.011","volume":"127","author":"X Jin","year":"2018","unstructured":"Jin X, Zhu DD, Chen BZ, Ashfaq M, Guo XD. Insulin delivery systems combined with microneedle technology. Adv Drug Deliv Rev. 2018;127:119\u201337. https:\/\/doi.org\/10.1016\/j.addr.2018.03.011.","journal-title":"Adv Drug Deliv Rev"},{"key":"3387_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.actbio.2023.09.010","volume":"171","author":"BZ Chen","year":"2023","unstructured":"Chen BZ, Li WX, Feng YH, Zhang XP, Jiao J, Li ZL, Nosrati-Siahmazgi V, Shahbazi M-A, Guo XD. Functional insulin aspart\/insulin degludec-based microneedles for promoting postprandial glycemic control. Acta Biomater. 2023;171:350\u201362. https:\/\/doi.org\/10.1016\/j.actbio.2023.09.010.","journal-title":"Acta Biomater"},{"key":"3387_CR74","doi-asserted-by":"publisher","unstructured":"Ma Y, Li CG, Kim S, Lahiji SF, Lee C, Jung H. An insulin microneedle pen (IMP) for self\u2010subcutaneous insulin injection. Adv Mater Technol. 2018. https:\/\/doi.org\/10.1002\/admt.201800234.","DOI":"10.1002\/admt.201800234"},{"key":"3387_CR75","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/acsbiomaterials.3c00137","volume":"9","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yu H, Wang L, Hu J, Feng J, Shen D, Hong Y, Liu J, Chen D. Microneedles with two-stage glucose-sensitive controlled release for long-term insulin delivery. ACS Biomater Sci Eng. 2023;9:2534\u201344. https:\/\/doi.org\/10.1021\/acsbiomaterials.3c00137.","journal-title":"ACS Biomater Sci Eng"},{"key":"3387_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2022.111217","author":"Q Zong","year":"2022","unstructured":"Zong Q, Zhou R, Zhao Z, Wang Y, Liu C, Zhang P. Glucose-responsive insulin microneedle patch based on phenylboronic acid for 1 diabetes treatment. Eur Polym J. 2022. https:\/\/doi.org\/10.1016\/j.eurpolymj.2022.111217.","journal-title":"Eur Polym J"},{"key":"3387_CR77","doi-asserted-by":"publisher","first-page":"20014","DOI":"10.1021\/acsami.8b04484","volume":"10","author":"Z Tong","year":"2018","unstructured":"Tong Z, Zhou J, Zhong J, Tang Q, Lei Z, Luo H, Ma P, Liu X. Glucose- and H2O2-responsive polymeric vesicles integrated with microneedle patches for glucose-sensitive transcutaneous delivery of insulin in diabetic rats. ACS Appl Mater Interfaces. 2018;10:20014\u201324. https:\/\/doi.org\/10.1021\/acsami.8b04484.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3387_CR78","doi-asserted-by":"publisher","unstructured":"Zhang XP, Jing LY, Feng YH, Jiao J, Li ZL, Yu BB, Yu R, Chen BZ, Shahbazi M-A, Guo XD. Assessing insulin stability in dissolving microneedles: potential for clinical applications. Health Eng. 2025. https:\/\/doi.org\/10.26599\/he.2024.9460003.","DOI":"10.26599\/he.2024.9460003"},{"key":"3387_CR79","doi-asserted-by":"publisher","first-page":"114586","DOI":"10.1016\/j.ejpb.2024.114586","volume":"206","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang Y, Zheng H, Yang X, Zou S, Chen J. Design, fabrication, and evaluation of antimicrobial sponge microneedles for the transdermal delivery of insulin. Eur J Pharm Biopharm. 2024;206:114586\u2013114586. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114586.","journal-title":"Eur J Pharm Biopharm"},{"key":"3387_CR80","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1021\/acs.molpharmaceut.4c00942","volume":"22","author":"F Smith","year":"2025","unstructured":"Smith F, Kotowska AM, Fiedler B, Cerny E, Cheung K, Rutland CS, Chowdhury F, Segal J, Rawson FJ, Marlow M. Using oscillation to improve the insertion depth and consistency of hollow microneedles for transdermal insulin delivery with mechanistic insights. Mol Pharm. 2025;22:316\u201329. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00942.","journal-title":"Mol Pharm"},{"key":"3387_CR81","unstructured":"Clinicaltrials.gov. 2025.  https:\/\/clinicaltrials.gov\/study\/NCT00837512. Accessed 25 Oct 2025."},{"key":"3387_CR82","unstructured":"Clinicaltrials.gov. (2025).  https:\/\/www.clinicaltrials.gov\/study\/NCT02837094. Accessed 25 Oct 2025."},{"key":"3387_CR83","unstructured":"Clinicaltrials.gov. (2025).  https:\/\/clinicaltrials.gov\/study\/NCT01557907. Accessed 25 Oct 2025."},{"key":"3387_CR84","unstructured":"Clinicaltrials.gov. 2025.  https:\/\/www.clinicaltrials.gov\/study\/NCT00602914. Accessed 25 Oct 2025."},{"key":"3387_CR85","unstructured":"Clinicaltrials.gov. 2025.  https:\/\/clinicaltrials.gov\/study\/NCT01061216. Accessed 25 Oct 2025."},{"key":"3387_CR86","unstructured":"Clinicaltrials.gov. 2025.https:\/\/clinicaltrials.gov\/study\/NCT01684956. Accessed 25 Oct 2025."},{"key":"3387_CR87","unstructured":"International Diabetes Federation. Diabetes around the World in 2025, IDF Diabetes Atlas; 2025. https:\/\/diabetesatlas.org\/. Accessed 28 Oct 2025."},{"key":"3387_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2023.170939","volume":"161","author":"CJ Bailey","year":"2023","unstructured":"Bailey CJ, Flatt PR, Conlon JM. An update on peptide-based therapies for type 2 diabetes and obesity. Peptides. 2023;161: 170939. https:\/\/doi.org\/10.1016\/j.peptides.2023.170939.","journal-title":"Peptides"},{"key":"3387_CR89","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","volume":"32","author":"K Iglay","year":"2016","unstructured":"Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, Moore LM, Rajpathak S. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32:1243\u201352. https:\/\/doi.org\/10.1185\/03007995.2016.1168291.","journal-title":"Curr Med Res Opin"},{"key":"3387_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10091616","volume":"10","author":"M Yang","year":"2022","unstructured":"Yang M, Liu S, Zhang C. The related metabolic diseases and treatments of obesity. Healthcare. 2022;10: 1616. https:\/\/doi.org\/10.3390\/healthcare10091616.","journal-title":"Healthcare"},{"key":"3387_CR91","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tem.2022.03.005","volume":"33","author":"JS Moon","year":"2022","unstructured":"Moon JS, Hong JH, Jung YJ, Ferrannini E, Nauck MA, Lim S. SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2022;33:424\u201342. https:\/\/doi.org\/10.1016\/j.tem.2022.03.005.","journal-title":"Trends Endocrinol Metab"},{"key":"3387_CR92","doi-asserted-by":"crossref","unstructured":"Latif W, Lambrinos KJ, Rodriguez R. Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs). 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/34283517\/. Accessed 30 Oct 2025.","DOI":"10.31031\/NPMS.2025.01.000518"},{"key":"3387_CR93","doi-asserted-by":"publisher","first-page":"101351","DOI":"10.1016\/j.molmet.2021.101351","volume":"57","author":"DJ Drucker","year":"2022","unstructured":"Drucker DJ. GLP-1 physiology informs the pharmacotherapy of obesity. Mol Metab. 2022;57:101351. https:\/\/doi.org\/10.1016\/j.molmet.2021.101351.","journal-title":"Mol Metab"},{"key":"3387_CR94","doi-asserted-by":"publisher","unstructured":"Singh P, Vinikoor T, Sharma N, Nelson N, Prasadh S, Oiknine R, et al. Single-administration self-boosting microneedle patch for the treatment of obesity. Adv Ther. 2024. https:\/\/doi.org\/10.1002\/adtp.202400028.","DOI":"10.1002\/adtp.202400028"},{"key":"3387_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061255","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu H, Zhang S, Zhou Z, Xing M, Gao Y. Two-layer sustained-release microneedles encapsulating exenatide for type 2 diabetes treatment. Pharmaceutics. 2022;14: 1255. https:\/\/doi.org\/10.3390\/pharmaceutics14061255.","journal-title":"Pharmaceutics"},{"key":"3387_CR96","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1021\/acs.molpharmaceut.5b00765","volume":"13","author":"S Liu","year":"2016","unstructured":"Liu S, Wu D, Quan Y-S, Kamiyama F, Kusamori K, Katsumi H, Sakane T, Yamamoto A. Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid. Mol Pharm. 2016;13:272\u20139. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00765.","journal-title":"Mol Pharm"},{"key":"3387_CR97","doi-asserted-by":"publisher","unstructured":"Fakhraei Lahiji S, Jang Y, Huh I, Yang H, Jang M, Jung H. Exendin-4\u2013encapsulated dissolving microneedle arrays for efficient treatment of type 2 diabetes. Sci Rep. 2018;8. https:\/\/doi.org\/10.1038\/s41598-018-19789-x.","DOI":"10.1038\/s41598-018-19789-x"},{"key":"3387_CR98","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2557938","volume":"32","author":"C Zhang","year":"2025","unstructured":"Zhang C, Long L, Hu H, Zhou X, Mao LF, Wang J, Zhang A, Wang Y, Yan Y, Mao S. Integrating micro-needle jet injection and sustained GLP-1 therapy with structured feeding: a comprehensive strategy for obesity management. Drug Deliv. 2025;32: 2557938. https:\/\/doi.org\/10.1080\/10717544.2025.2557938.","journal-title":"Drug Deliv"},{"key":"3387_CR99","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1073\/pnas.1601653113","volume":"113","author":"P-Y Yang","year":"2016","unstructured":"Yang P-Y, Zou H, Chao E, Sherwood L, Nunez V, Keeney M, Ghartey-Tagoe E, Ding Z, Quirino H, Luo X, Welzel G, Chen G, Singh P, Woods AK, Schultz PG, Shen W. Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery. Proc Natl Acad Sci USA. 2016;113:4140\u20135. https:\/\/doi.org\/10.1073\/pnas.1601653113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3387_CR100","doi-asserted-by":"publisher","unstructured":"Lin H, Liu J, Hou Y, Yu Z, Hong J, Yu J, et al. Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs. Drug Deliv Transl Res. 2024. https:\/\/doi.org\/10.1007\/s13346-024-01582-1.","DOI":"10.1007\/s13346-024-01582-1"},{"key":"3387_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146884","volume":"322","author":"T Jia","year":"2025","unstructured":"Jia T, Geng Y, Shao H, Tan G, Zhang X, Kundu SC, Lu S. Silk fibroin hollow microneedle system for sustained transdermal administration of liraglutide: development and characterization. Int J Biol Macromol. 2025;322: 146884. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146884.","journal-title":"Int J Biol Macromol"},{"key":"3387_CR102","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1039\/d2lc01084d","volume":"23","author":"S Juhng","year":"2023","unstructured":"Juhng S, Song J, You J, Park J, Yang H, Jang M, Kang G, Shin J, Ko HW, Jung H. Fabrication of liraglutide-encapsulated triple layer hyaluronic acid microneedles (TLMs) for the treatment of obesity. Lab Chip. 2023;23:2378\u201388. https:\/\/doi.org\/10.1039\/d2lc01084d.","journal-title":"Lab Chip"},{"key":"3387_CR103","doi-asserted-by":"publisher","unstructured":"Udeabor SE. Monoclonal antibodies in modern medicine: their therapeutic potential and future directions. Trends Pharm Biotechnol. 2024;2:12\u201320. https:\/\/doi.org\/10.57238\/tpb.2024.153196.1019.","DOI":"10.57238\/tpb.2024.153196.1019"},{"key":"3387_CR104","doi-asserted-by":"publisher","unstructured":"Kothari M, Wanjari A, Acharya S, Karwa V, Chavhan R, Kumar S, Kadu A, Patil R, Kothari M, Wanjari A, Acharya S, Karwa V, Chavhan R, Kumar S, Kadu A, Patil R. A comprehensive review of monoclonal antibodies in modern medicine: tracing the evolution of a revolutionary therapeutic approach. Cureus. 2024;16. https:\/\/doi.org\/10.7759\/cureus.61983.","DOI":"10.7759\/cureus.61983"},{"key":"3387_CR105","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/acs.bioconjchem.3c00374","volume":"34","author":"JM Sasso","year":"2023","unstructured":"Sasso JM, Tenchov R, Bird RE, Iyer KA, Ralhan K, Rodr\u00edguez Y, Zhou Q. The evolving landscape of antibody\u2013drug conjugates: in depth analysis of recent research progress. Bioconjug Chem. 2023;34:1951\u20132000. https:\/\/doi.org\/10.1021\/acs.bioconjchem.3c00374.","journal-title":"Bioconjug Chem"},{"key":"3387_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112533","volume":"14","author":"M Akbarian","year":"2022","unstructured":"Akbarian M, Chen S-H. Instability challenges and stabilization strategies of pharmaceutical proteins. Pharmaceutics. 2022;14: 2533. https:\/\/doi.org\/10.3390\/pharmaceutics14112533.","journal-title":"Pharmaceutics"},{"key":"3387_CR107","doi-asserted-by":"publisher","unstructured":"Kaur H. Stability testing in monoclonal antibodies. Crit Rev Biotechnol. 2021;1\u201332. https:\/\/doi.org\/10.1080\/07388551.2021.1874281.","DOI":"10.1080\/07388551.2021.1874281"},{"key":"3387_CR108","doi-asserted-by":"publisher","first-page":"35947","DOI":"10.1039\/D3RA06476J","volume":"13","author":"M Rahban","year":"2023","unstructured":"Rahban M, Ahmad F, Piatyszek MA, Haertl\u00e9 T, Saso L, Saboury AA. Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry. RSC Adv. 2023;13:35947\u201363. https:\/\/doi.org\/10.1039\/D3RA06476J.","journal-title":"RSC Adv"},{"key":"3387_CR109","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/medicines12010004","volume":"12","author":"HX Nguyen","year":"2025","unstructured":"Nguyen HX. Beyond the needle: innovative microneedle-based transdermal vaccination. Medicines (Basel). 2025;12:4. https:\/\/doi.org\/10.3390\/medicines12010004.","journal-title":"Medicines (Basel)"},{"key":"3387_CR110","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1016\/j.xphs.2016.07.008","volume":"105","author":"E Korkmaz","year":"2016","unstructured":"Korkmaz E, Friedrich EE, Ramadan MH, Erdos G, Mathers AR, Ozdoganlar OB, Washburn NR, Falo LD. Tip-loaded dissolvable microneedle arrays effectively deliver polymer-conjugated antibody inhibitors of tumor-necrosis-factor-alpha into human skin. J Pharm Sci. 2016;105:3453\u20137. https:\/\/doi.org\/10.1016\/j.xphs.2016.07.008.","journal-title":"J Pharm Sci"},{"key":"3387_CR111","doi-asserted-by":"publisher","unstructured":"Jacobse J, Ten Voorde W, Tandon A, Romeijn SG, Grievink HW, van der Maaden K, van Esdonk MJ, Moes DJAR, Loeff F, Bloem K, de Vries A, Rispens T, Wolbink G, de Kam M, Ziagkos D, Moerland M, Jiskoot W, Bouwstra J, Burggraaf J, Schrier L. Comprehensive evaluation of microneedle\u2010based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial. Br J Clin Pharmacol. 2021;87:3162\u20133176. https:\/\/doi.org\/10.1111\/bcp.14729.","DOI":"10.1111\/bcp.14729"},{"key":"3387_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202205847","volume":"32","author":"D Wu","year":"2022","unstructured":"Wu D, Shou X, Yu Y, Wang X, Chen G, Zhao Y, Sun L. Biologics\u2010loaded photothermally dissolvable hyaluronic acid microneedle patch for psoriasis treatment. Adv Funct Mater. 2022;32: 2205847. https:\/\/doi.org\/10.1002\/adfm.202205847.","journal-title":"Adv Funct Mater"},{"key":"3387_CR113","doi-asserted-by":"publisher","first-page":"101905","DOI":"10.1016\/j.mtbio.2025.101905","volume":"33","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chen J, Huang N, Chen Q, Farooq MA, Ouyang P, Huang K, Liao K, He W, Cui K, Jiang D, Xu G. Microneedle-based sustained release delivery of TNF-\u03b1\/IL-6R dual-specific fenobody alleviates inflammation and promotes bone regeneration in rheumatoid arthritis rat model. Mater Today Bio. 2025;33:101905. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101905.","journal-title":"Mater Today Bio"},{"key":"3387_CR114","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s13346-015-0250-2","volume":"5","author":"R Donnelly","year":"2015","unstructured":"Donnelly R, Douroumis D. Microneedles for drug and vaccine delivery and patient monitoring. Drug Deliv Transl Res. 2015;5:311\u20132. https:\/\/doi.org\/10.1007\/s13346-015-0250-2.","journal-title":"Drug Deliv Transl Res"},{"key":"3387_CR115","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/17425247.2018.1522301","volume":"15","author":"AM Rodgers","year":"2018","unstructured":"Rodgers AM, Courtenay AJ, Donnelly RF. Dissolving microneedles for intradermal vaccination: manufacture, formulation, and stakeholder considerations. Expert Opin Drug Deliv. 2018;15:1039\u201343. https:\/\/doi.org\/10.1080\/17425247.2018.1522301.","journal-title":"Expert Opin Drug Deliv"},{"key":"3387_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5281\/zenodo.15630446","volume":"4","author":"G George","year":"2025","unstructured":"George G, Shahul DA. Needle-free injection technology: transforming healthcare delivery through innovation and trust-building. Partn Univers Int Res J. 2025;4:1\u201314. https:\/\/doi.org\/10.5281\/zenodo.15630446.","journal-title":"Partn Univers Int Res J"},{"key":"3387_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/bmm2.70001","author":"SWA Shah","year":"2025","unstructured":"Shah SWA, Li X, Yuan H, Shen H, Quan S, Pan G, Ishfaq M, Shah AU, Xie H, Shao J. Innovative transdermal drug delivery systems: benefits, challenges, and emerging application. BMEMat. 2025. https:\/\/doi.org\/10.1002\/bmm2.70001.","journal-title":"BMEMat"},{"key":"3387_CR118","unstructured":"Jain KK. Transdermal drug delivery: technologies, companies & markets. 2021. https:\/\/www.researchgate.net\/publication\/371938157_Transdermal_Drug_Delivery_Technologies_Companies_Markets. Accessed 3 Nov 2025."},{"key":"3387_CR119","doi-asserted-by":"crossref","unstructured":"Donnelly RF, Thakur. Novel delivery systems for transdermal and intradermal drug delivery. Wiley; 2015","DOI":"10.1002\/9781118734506"},{"key":"3387_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22:1\u201323. https:\/\/doi.org\/10.1038\/s41573-023-00670-0.","journal-title":"Nat Rev Drug Discov"},{"key":"3387_CR121","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/vaccines13090978","volume":"13","author":"M Gulani","year":"2025","unstructured":"Gulani M, Arte T, Ferguson A, Pasupuleti D, Adediran E, Harsoda Y, McCommon AN, Gala R, D\u2019Souza MJ. Recent advancements in non-invasive vaccination strategies. Vaccines. 2025;13:978\u2013978. https:\/\/doi.org\/10.3390\/vaccines13090978.","journal-title":"Vaccines"},{"key":"3387_CR122","doi-asserted-by":"publisher","unstructured":"Papania MJ, Zehrung D, Jarrahian C. Technologies to improve immunization, Plotkin\u2019s vaccines. 2018;1320\u201353.e17. https:\/\/doi.org\/10.1016\/B978-0-323-35761-6.00068-7.","DOI":"10.1016\/B978-0-323-35761-6.00068-7"},{"key":"3387_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020304","volume":"8","author":"C Lemoine","year":"2020","unstructured":"Lemoine C, Thakur A, Kraji\u0161nik D, Guyon R, Longet S, Razim A, G\u00f3rska S, Panteli\u0107 I, Ili\u0107 T, Nikoli\u0107 I, Lavelle EC, Gamian A, Savi\u0107 S, Milicic A. Technological approaches for improving vaccination compliance and coverage. Vaccines. 2020;8: 304. https:\/\/doi.org\/10.3390\/vaccines8020304.","journal-title":"Vaccines"},{"key":"3387_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/smo.20240067","volume":"3","author":"H Jia","year":"2025","unstructured":"Jia H, Liu J, Shi M, Abbas M, Xing R, Yan X. Microneedle delivery systems for vaccines and immunotherapy. Smart Molecules. 2025;3: e20240067. https:\/\/doi.org\/10.1002\/smo.20240067.","journal-title":"Smart Molecules"},{"key":"3387_CR125","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jconrel.2018.12.026","volume":"294","author":"L Niu","year":"2019","unstructured":"Niu L, Chu LY, Burton SA, Hansen KJ, Panyam J. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. J Control Release. 2019;294:268\u201378. https:\/\/doi.org\/10.1016\/j.jconrel.2018.12.026.","journal-title":"J Control Release"},{"key":"3387_CR126","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2017.09.021","volume":"266","author":"G Du","year":"2017","unstructured":"Du G, Hathout RM, Nasr M, Nejadnik MR, Tu J, Koning RI, Koster AJ, Sl\u00fctter B, Kros A, Jiskoot W, Bouwstra JA, M\u00f6nk\u00e4re J. Intradermal vaccination with hollow microneedles: a comparative study of various protein antigen and adjuvant encapsulated nanoparticles. J Control Release. 2017;266:109\u201318. https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.021.","journal-title":"J Control Release"},{"key":"3387_CR127","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.actbio.2019.07.048","volume":"97","author":"Y-H Chen","year":"2019","unstructured":"Chen Y-H, Lai K-Y, Chiu Y-H, Wu Y-W, Shiau A-L, Chen M-C. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination. Acta Biomater. 2019;97:230\u20138. https:\/\/doi.org\/10.1016\/j.actbio.2019.07.048.","journal-title":"Acta Biomater"},{"key":"3387_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0838-7","volume":"15","author":"O Proudfoot","year":"2015","unstructured":"Proudfoot O, Esparon S, Tang C-K, Laurie K, Barr I, Pietersz G. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung. BMC Infect Dis. 2015;15: 101. https:\/\/doi.org\/10.1186\/s12879-015-0838-7.","journal-title":"BMC Infect Dis"},{"key":"3387_CR129","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","volume":"18","author":"I Soerjomataram","year":"2021","unstructured":"Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070. Nat Rev Clin Oncol. 2021;18:663\u201372. https:\/\/doi.org\/10.1038\/s41571-021-00514-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"3387_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08610-1","author":"N Wang","year":"2022","unstructured":"Wang N, Chen J, Chen W, Shi Z, Yang H, Liu P, Wei X, Dong X, Wang C, Mao L, Li X. The effectiveness of case management for cancer patients: an umbrella review. BMC Health Serv Res. 2022. https:\/\/doi.org\/10.1186\/s12913-022-08610-1.","journal-title":"BMC Health Serv Res"},{"key":"3387_CR131","doi-asserted-by":"publisher","unstructured":"Huang, Zhou W. Mn-based cGAS-STING activation for tumor therapy. Chin J Cancer Res. 2023;35:19\u201343. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.01.04.","DOI":"10.21147\/j.issn.1000-9604.2023.01.04"},{"key":"3387_CR132","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cclet.2021.01.036","volume":"32","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen Q, Zhu H, Yin X, Wang K, Liu Y, Zhao W. Enhancing the immune response and tumor suppression effect of antitumor vaccines adjuvanted with non-nucleotide small molecule STING agonist. Chin Chem Lett. 2021;32:1888\u201392. https:\/\/doi.org\/10.1016\/j.cclet.2021.01.036.","journal-title":"Chin Chem Lett"},{"key":"3387_CR133","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18:175\u201396. https:\/\/doi.org\/10.1038\/s41573-018-0006-z.","journal-title":"Nat Rev Drug Discov"},{"key":"3387_CR134","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.apsb.2022.09.015","volume":"13","author":"Z Feng","year":"2023","unstructured":"Feng Z, Wang Y, Xu H, Guo Y, Xia W, Zhao C, Zhao X, Wu J. Recent advances in bacterial therapeutics based on sense and response. Acta Pharm Sin B. 2023;13:1014\u201327. https:\/\/doi.org\/10.1016\/j.apsb.2022.09.015.","journal-title":"Acta Pharm Sin B"},{"key":"3387_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202201403","author":"K Xiong","year":"2022","unstructured":"Xiong K, Wei F, Chen Y, Ji L, Chao H. Recent progress in photodynamic immunotherapy with metal\u2010based photosensitizers. Small Methods. 2022. https:\/\/doi.org\/10.1002\/smtd.202201403.","journal-title":"Small Methods"},{"key":"3387_CR136","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/nejmoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411\u201322. https:\/\/doi.org\/10.1056\/nejmoa1001294.","journal-title":"N Engl J Med"},{"key":"3387_CR137","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout SZ, Miller DM, Emerick KS, Kaufman HL. Therapy with oncolytic viruses: progress and challenges. Nat Rev Clin Oncol. 2023;20:160\u201377. https:\/\/doi.org\/10.1038\/s41571-022-00719-w.","journal-title":"Nat Rev Clin Oncol"},{"key":"3387_CR138","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/21645515.2015.1010871","volume":"11","author":"Y Levin","year":"2015","unstructured":"Levin Y, Kochba E, Hung I, Kenney R. Intradermal vaccination using the novel microneedle device MicronJet600: past, present, and future. Hum Vaccin Immunother. 2015;11:991\u20137. https:\/\/doi.org\/10.1080\/21645515.2015.1010871.","journal-title":"Hum Vaccin Immunother"},{"key":"3387_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120410","volume":"264","author":"D Li","year":"2021","unstructured":"Li D, Hu D, Xu H, Patra HK, Liu X, Zhou Z, Tang J, Slater N, Shen Y. Progress and perspective of microneedle system for anti-cancer drug delivery. Biomaterials. 2021;264: 120410. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120410.","journal-title":"Biomaterials"},{"key":"3387_CR140","doi-asserted-by":"publisher","first-page":"108706","DOI":"10.1016\/j.cclet.2023.108706","volume":"35","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhu J, Ding J, Zhou W. Recent progress of vaccines administration via microneedles for cancer immunotherapy. Chin Chem Lett. 2023;35:108706. https:\/\/doi.org\/10.1016\/j.cclet.2023.108706.","journal-title":"Chin Chem Lett"},{"key":"3387_CR141","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jconrel.2023.07.002","volume":"360","author":"Y Tian","year":"2023","unstructured":"Tian Y, Jing H, Wang Q, Hu S, Wu Z, Duan Y. Dissolving microneedles-based programmed delivery system for enhanced chemo-immunotherapy of melanoma. J Control Release. 2023;360:630\u201346. https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.002.","journal-title":"J Control Release"},{"key":"3387_CR142","doi-asserted-by":"publisher","first-page":"e2500015","DOI":"10.1002\/smll.202500015","volume":"21","author":"Q-H Xu","year":"2025","unstructured":"Xu Q-H, Yin X-Y, Chen Z-Q, Huang E-K, Yao X, Li X, Liu P-N. Construction of in situ personalized cancer vaccines by bioorthogonal catalytic microneedles for augmented melanoma immunotherapy. Small. 2025;21:e2500015. https:\/\/doi.org\/10.1002\/smll.202500015.","journal-title":"Small"},{"key":"3387_CR143","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.7150\/thno.112475","volume":"15","author":"C Guo","year":"2025","unstructured":"Guo C, Lin L, Wang Y, Jing J, Gong Q, Luo K. Nano drug delivery systems for advanced immune checkpoint blockade therapy. Theranostics. 2025;15:5440\u201380. https:\/\/doi.org\/10.7150\/thno.112475.","journal-title":"Theranostics"},{"key":"3387_CR144","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bioactmat.2024.11.006","volume":"45","author":"C D\u2019Amico","year":"2024","unstructured":"D\u2019Amico C, Fusciello M, Hamdan F, D\u2019Alessio F, Bottega P, Saklauskaite M, Russo S, Cerioni J, Elbadri K, Kemell M, Hirvonen J, Cerullo V, Santos HA. Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches. Bioact Mater. 2024;45:115\u201327. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.11.006.","journal-title":"Bioact Mater"},{"key":"3387_CR145","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.actbio.2025.04.039","volume":"199","author":"J Wang","year":"2025","unstructured":"Wang J, Huang S, Wei H, Liang S, Ding Y, Xiao Z, Shuai X. A dissolvable microneedle platform for the delivery of tumor-derived total RNA nanovaccines for enhanced tumor immunotherapy. Acta Biomater. 2025;199:120\u201331. https:\/\/doi.org\/10.1016\/j.actbio.2025.04.039.","journal-title":"Acta Biomater"},{"key":"3387_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113726","volume":"383","author":"N Li","year":"2025","unstructured":"Li N, Mu W, Xia Z, Ma Q, Zhang N. Soluble-microneedle enhance three T-cell activation signals as efficient tumor vaccines for melanoma prevention and treatment. J Control Release. 2025;383: 113726. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113726.","journal-title":"J Control Release"},{"key":"3387_CR147","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1016\/j.mtbio.2025.102158","volume":"34","author":"H Yu","year":"2025","unstructured":"Yu H, Chen Y, Yin J, Yuan Z, Feng S, Duan Y, Yan P, Liu S, Zhu W. Light-controlled pyroptosis via redox-responsive microneedles enhances photodynamic-epigenetic immunotherapy in breast cancer. Mater Today Bio. 2025;34:102158. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102158.","journal-title":"Mater Today Bio"},{"key":"3387_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.02.040","volume":"128","author":"J Arya","year":"2017","unstructured":"Arya J, Henry S, Kalluri H, McAllister DV, Pewin WP, Prausnitz MR. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 2017;128:1\u20137. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.02.040.","journal-title":"Biomaterials"},{"key":"3387_CR149","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1016\/j.vaccine.2017.07.083","volume":"35","author":"S Marshall","year":"2017","unstructured":"Marshall S, Fleming A, Moore AC, Sahm LJ. Acceptability of microneedle-patch vaccines: a qualitative analysis of the opinions of parents. Vaccine. 2017;35:4896\u2013904. https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.083.","journal-title":"Vaccine"},{"key":"3387_CR150","doi-asserted-by":"publisher","unstructured":"Roy S, Das D, Chaudhury JK, Ray K, Laha S, Dinda SC, Bose A. An insight investigation on steady-state pharmacokinetics of lobeglitazone-loaded dissolving microneedles in rats, Asian J Pharm Clin Res. 2025;104\u2013110. https:\/\/doi.org\/10.22159\/ajpcr.2025v18i9.55996.","DOI":"10.22159\/ajpcr.2025v18i9.55996"},{"key":"3387_CR151","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11095-022-03254-6","volume":"39","author":"Y-J Oh","year":"2022","unstructured":"Oh Y-J, Kang N-W, Jeong H-R, Sohn S-Y, Jeon Y-E, Yu N-Y, Hwang Y, Kim S, Kim D-D, Park J-H. The relationship between the drug delivery properties of a formulation of Teriparatide microneedles and the pharmacokinetic evaluation of teriparatide administration in rats. Pharm Res. 2022;39:989\u201399. https:\/\/doi.org\/10.1007\/s11095-022-03254-6.","journal-title":"Pharm Res"},{"key":"3387_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114517","author":"L Koenitz","year":"2024","unstructured":"Koenitz L, Crean A, Vucen S. Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics. Eur J Pharm Biopharm. 2024. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114517.","journal-title":"Eur J Pharm Biopharm"},{"key":"3387_CR153","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-021-06559-x","author":"RS Bhadale","year":"2021","unstructured":"Bhadale RS, Londhe VY. A systematic review of carbohydrate-based microneedles: current status and future prospects. J Mater Sci Mater Med. 2021. https:\/\/doi.org\/10.1007\/s10856-021-06559-x.","journal-title":"J Mater Sci Mater Med"},{"key":"3387_CR154","doi-asserted-by":"publisher","unstructured":"Reinke, Whiteside EJ, Windus L, Desai D, Stehr E, Rad ZF. The advantages of microneedle patches compared to conventional needle-based drug delivery and biopsy devices in medicine. Biomed Eng Adv. 2024;100127. https:\/\/doi.org\/10.1016\/j.bea.2024.100127.","DOI":"10.1016\/j.bea.2024.100127"},{"key":"3387_CR155","doi-asserted-by":"publisher","unstructured":"Chandler CE, Harberts EM, Laemmermann T, Zeng Q, Opene BN, Germain RN, Jewell CM, Scott AJ, Ernst RK. In vivo intradermal delivery of bacteria by using microneedle arrays. Infect Immun. 2018;86.\u00a0https:\/\/doi.org\/10.1128\/iai.00406-18.","DOI":"10.1128\/iai.00406-18"},{"key":"3387_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/polym13152405","volume":"13","author":"S Mdanda","year":"2021","unstructured":"Mdanda S, Ubanako P, Kondiah PPD, Kumar P, Choonara YE. Recent advances in microneedle platforms for transdermal drug delivery technologies. Polymers. 2021;13: 2405. https:\/\/doi.org\/10.3390\/polym13152405.","journal-title":"Polymers"},{"key":"3387_CR157","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/1061186x.2016.1200589","volume":"25","author":"H-R Jeong","year":"2016","unstructured":"Jeong H-R, Lee H-S, Choi I-J, Park J-H. Considerations in the use of microneedles: pain, convenience, anxiety and safety. J Drug Target. 2016;25:29\u201340. https:\/\/doi.org\/10.1080\/1061186x.2016.1200589.","journal-title":"J Drug Target"},{"key":"3387_CR158","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/s0140-6736(17)30575-5","volume":"390","author":"NG Rouphael","year":"2017","unstructured":"Rouphael NG, Paine M, Mosley R, Henry S, McAllister DV, Kalluri H, Pewin W, Frew PM, Yu T, Thornburg NJ, Kabbani S, Lai L, Vassilieva EV, Skountzou I, Compans RW, Mulligan MJ, Prausnitz MR, Beck A, Edupuganti S, Heeke S. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017;390:649\u201358. https:\/\/doi.org\/10.1016\/s0140-6736(17)30575-5.","journal-title":"Lancet"},{"key":"3387_CR159","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/17425247.2018.1410138","volume":"15","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Park JH. Human studies with microneedles for evaluation of their efficacy and safety. Expert Opin Drug Deliv. 2017;15:235\u201345. https:\/\/doi.org\/10.1080\/17425247.2018.1410138.","journal-title":"Expert Opin Drug Deliv"},{"key":"3387_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.sintl.2024.100325","volume":"6","author":"O Sen","year":"2025","unstructured":"Sen O, Poddar P, Sarkar P, Das S, Manna S. Current advancements in microneedle technology for therapeutic and biomedical applications. Sensors International. 2025;6: 100325. https:\/\/doi.org\/10.1016\/j.sintl.2024.100325.","journal-title":"Sensors International"},{"key":"3387_CR161","doi-asserted-by":"publisher","unstructured":"Li Y, Chen Q, Wang T, Ji Z, Regmi S, Tong H, et al. Advances in microneedle-based drug delivery system for metabolic diseases: structural considerations, design strategies, and future perspectives. J Nanobiotechnol. 2025;23. https:\/\/doi.org\/10.1186\/s12951-025-03432-9.","DOI":"10.1186\/s12951-025-03432-9"},{"key":"3387_CR162","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jocd.13888","volume":"20","author":"LA del Rio","year":"2020","unstructured":"del Rio LA, Baeza D, Salazar N. Microneedle systems as medical devices for esthetical treatments: a risk assessment approach. J Cosmet Dermatol. 2020;20:2052\u20137. https:\/\/doi.org\/10.1111\/jocd.13888.","journal-title":"J Cosmet Dermatol"},{"key":"3387_CR163","doi-asserted-by":"publisher","first-page":"82","DOI":"10.22270\/ijdra.v12i4.724","volume":"12","author":"NA Patil","year":"2024","unstructured":"Patil NA, Kuchal MD, Domaraju P. Comparison of GMP for drugs in EU, US, Canada, WHO and Australia. Int J Drug Regul Aff. 2024;12:82\u201391. https:\/\/doi.org\/10.22270\/ijdra.v12i4.724.","journal-title":"Int J Drug Regul Aff"},{"key":"3387_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/gels9100806","volume":"9","author":"B Shriky","year":"2023","unstructured":"Shriky B, Babenko M, Whiteside BR. Dissolving and swelling hydrogel-based microneedles: an overview of their materials, fabrication, characterization methods, and challenges. Gels. 2023;9: 806. https:\/\/doi.org\/10.3390\/gels9100806.","journal-title":"Gels"},{"key":"3387_CR165","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/00914037.2020.1798442","volume":"71","author":"W Cheng","year":"2020","unstructured":"Cheng W, Sun M, Xing S, Zhang Y. Gao, The hygroscopicity of polymer microneedles on the performance of dissolving behavior for transdermal delivery. International Journal of Polymeric Materials and Polymeric Biomaterials. 2020;71:72\u20138. https:\/\/doi.org\/10.1080\/00914037.2020.1798442.","journal-title":"International Journal of Polymeric Materials and Polymeric Biomaterials"},{"key":"3387_CR166","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-023-00658-y","author":"X Luo","year":"2023","unstructured":"Luo X, Yang L, Cui Y. Microneedles: materials, fabrication, and biomedical applications. Biomed Microdevices. 2023. https:\/\/doi.org\/10.1007\/s10544-023-00658-y.","journal-title":"Biomed Microdevices"},{"key":"3387_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122234","volume":"628","author":"F Smith","year":"2022","unstructured":"Smith F, Sabri AH, Heppel M, Fonseca I, Chowdhury F, Cheung K, Willmor S, Rawson F, Marlow M. The clinical and translational prospects of microneedle devices, with a focus on insulin therapy for diabetes mellitus as a case study. Int J Pharm. 2022;628: 122234. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122234.","journal-title":"Int J Pharm"},{"key":"3387_CR168","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13346-015-0237-z","volume":"5","author":"REM Lutton","year":"2015","unstructured":"Lutton REM, Moore J, Larra\u00f1eta E, Ligett S, Woolfson AD, Donnelly RF. Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res. 2015;5:313\u201331. https:\/\/doi.org\/10.1007\/s13346-015-0237-z.","journal-title":"Drug Deliv Transl Res"},{"key":"3387_CR169","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/pharmaceutics17050550","volume":"17","author":"S Sarvepalli","year":"2025","unstructured":"Sarvepalli S, Pasika SR, Verma V, Thumma A, Bolla S, Nukala PK, Butreddy A, Bolla PK. A Review on the Stability Challenges of Advanced Biologic Therapeutics. Pharmaceutics. 2025;17:550\u2013550. https:\/\/doi.org\/10.3390\/pharmaceutics17050550.","journal-title":"Pharmaceutics"},{"key":"3387_CR170","doi-asserted-by":"publisher","unstructured":"Pathania S, Parmar P, Tiwari BK. Stability of proteins during processing and storage, proteins: sustainable source. Process Appl. 2019;295\u2013330. https:\/\/doi.org\/10.1016\/b978-0-12-816695-6.00010-6.","DOI":"10.1016\/b978-0-12-816695-6.00010-6"},{"key":"3387_CR171","doi-asserted-by":"publisher","DOI":"10.1038\/srep46568","author":"Y-C Chen","year":"2017","unstructured":"Chen Y-C, Smith T, Hicks RH, Doekhie A, Koumanov F, Wells SA, Edler KJ, van den Elsen J, Holman GD, Marchbank KJ, Sartbaeva A. Thermal stability, storage and release of proteins with tailored fit in silica. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/srep46568.","journal-title":"Sci Rep"},{"key":"3387_CR172","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03127-2","volume":"26","author":"K Gopal","year":"2025","unstructured":"Gopal K, Mahmood S, Sofian ZM, Hilles AR, Hashim NM. Microneedle innovations in oral therapeutics: transforming protein and peptide delivery. AAPS PharmSciTech. 2025;26: 146. https:\/\/doi.org\/10.1208\/s12249-025-03127-2.","journal-title":"AAPS PharmSciTech"},{"key":"3387_CR173","doi-asserted-by":"publisher","DOI":"10.1093\/rpsppr\/rqae018","author":"L Koenitz","year":"2024","unstructured":"Koenitz L, Crean A, Vucen S. Stress factors affecting protein stability during the fabrication and storage of dissolvable microneedles. RPS Pharmacy and Pharmacology Reports. 2024. https:\/\/doi.org\/10.1093\/rpsppr\/rqae018.","journal-title":"RPS Pharmacy and Pharmacology Reports"},{"key":"3387_CR174","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopha.2017.07.019","volume":"93","author":"K Ita","year":"2017","unstructured":"Ita K. Dissolving microneedles for transdermal drug delivery: advances and challenges. Biomed Pharmacother. 2017;93:1116\u201327. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.019.","journal-title":"Biomed Pharmacother"},{"key":"3387_CR175","doi-asserted-by":"publisher","first-page":"115109","DOI":"10.1016\/j.addr.2023.115109","volume":"203","author":"BZ Chen","year":"2023","unstructured":"Chen BZ, He YT, Zhao ZQ, Feng YH, Liang L, Peng J, Yang CY, Uyama H, Shahbazi M-A, Guo XD. Strategies to develop polymeric microneedles for controlled drug release. Adv Drug Deliv Rev. 2023;203:115109\u2013115109. https:\/\/doi.org\/10.1016\/j.addr.2023.115109.","journal-title":"Adv Drug Deliv Rev"},{"key":"3387_CR176","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13346-014-0211-1","volume":"5","author":"MTC McCrudden","year":"2014","unstructured":"McCrudden MTC, Alkilani AZ, Courtenay AJ, McCrudden CM, McCloskey B, Walker C, Alshraiedeh N, Lutton REM, Gilmore BF, Woolfson AD, Donnelly RF. Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res. 2014;5:3\u201314. https:\/\/doi.org\/10.1007\/s13346-014-0211-1.","journal-title":"Drug Deliv Transl Res"},{"key":"3387_CR177","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/03639045.2020.1742144","volume":"46","author":"HP Swathi","year":"2020","unstructured":"Swathi HP, Matadh VA, Guin JP, Murthy SN, Kanni P, Varshney L, Suresh S, Shivakumar HN. Effect of gamma sterilization on the properties of microneedle array transdermal patch system. Drug Dev Ind Pharm. 2020;46:606\u201320. https:\/\/doi.org\/10.1080\/03639045.2020.1742144.","journal-title":"Drug Dev Ind Pharm"},{"key":"3387_CR178","doi-asserted-by":"publisher","first-page":"756","DOI":"10.18063\/ijb.756","volume":"9","author":"A Valls-Esteve","year":"2023","unstructured":"Valls-Esteve A, Lustig-Gainza P, Adell-Gomez N, Tejo-Otero A, Engl\u00ed-Rueda M, Julian-Alvarez E, Navarro-Sureda O, Fenollosa-Art\u00e9s F, Rubio-Palau J, Krauel L, Munuera J. A state-of-the-art guide about the effects of sterilization processes on 3D-printed materials for surgical planning and medical applications: A comparative study. Int J Bioprint. 2023;9:756\u2013756. https:\/\/doi.org\/10.18063\/ijb.756.","journal-title":"Int J Bioprint"},{"key":"3387_CR179","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.3390\/polym15163461","volume":"15","author":"N Krug","year":"2023","unstructured":"Krug N, Zarges J-C, Heim H. Influence of Ethylene Oxide and Gamma Irradiation Sterilization Processes on the Properties of Poly-L-Lactic-Acid (PLLA) Materials. Polymers. 2023;15:3461\u20133461. https:\/\/doi.org\/10.3390\/polym15163461.","journal-title":"Polymers"},{"key":"3387_CR180","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5604\/01.3001.0012.1264","volume":"2","author":"P Bednarz","year":"2018","unstructured":"Bednarz P, Bernasik A, Laska J. The influence of sterilization on properties of polyurethane\/polylactide blend. Science, Technology and Innovation. 2018;2:13\u20138. https:\/\/doi.org\/10.5604\/01.3001.0012.1264.","journal-title":"Science, Technology and Innovation"},{"key":"3387_CR181","unstructured":"WHO. Annex 6 WHO good manufacturing practices for sterile pharmaceutical products. 2011. https:\/\/www.who.int\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/production\/trs961-annex6-gmp-sterile-pharmaceutical-products.pdf. Accessed 5 Nov 2025."},{"key":"3387_CR182","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1016\/j.vaccine.2015.02.076","volume":"33","author":"BY Lee","year":"2015","unstructured":"Lee BY, Bartsch SM, Mvundura M, Jarrahian C, Zapf KM, Marinan K, Wateska AR, Snyder B, Swaminathan S, Jacoby E, Norman JJ, Prausnitz MR, Zehrung D. An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. Vaccine. 2015;33:4727\u201336. https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.076.","journal-title":"Vaccine"},{"key":"3387_CR183","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40268-016-0144-x","volume":"16","author":"BB Adhikari","year":"2016","unstructured":"Adhikari BB, Goodson JL, Chu SY, Rota PA, Meltzer MI. Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: the case for further research and development. Drugs R D. 2016;16:327\u201338. https:\/\/doi.org\/10.1007\/s40268-016-0144-x.","journal-title":"Drugs R D"},{"key":"3387_CR184","unstructured":"Sandle T. History and development of cleanrooms: an updated review. ResearchGate. 2021;21\u201330.  https:\/\/www.researchgate.net\/publication\/353765090_History_and_development_of_cleanrooms_An_updated_review. Accessed 17 Nov 2025."},{"key":"3387_CR185","unstructured":"Quinten T, Beer TD, Remon JP, Vervaet C. Overview of injection molding as a manufacturing technique for pharmaceutical applications. 2011. pp. 1\u201342. https:\/\/www.researchgate.net\/publication\/287590984_Overview_of_injection_molding_as_a_manufacturing_technique_for_pharmaceutical_applications. Accessed 6 Nov 2025."},{"key":"3387_CR186","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1021\/acssensors.0c00404","volume":"5","author":"C Liedert","year":"2020","unstructured":"Liedert C, Rannaste L, Kokkonen A, Huttunen O-H, Liedert R, Hiltunen J, Hakalahti L. Roll-to-roll manufacturing of integrated immunodetection sensors. ACS Sens. 2020;5:2010\u20137. https:\/\/doi.org\/10.1021\/acssensors.0c00404.","journal-title":"ACS Sens"},{"key":"3387_CR187","doi-asserted-by":"publisher","unstructured":"Donnelly RF. Clinical translation and industrial development of microneedle\u2010based products. 2018;307\u201322. https:\/\/doi.org\/10.1002\/9781119305101.ch11.","DOI":"10.1002\/9781119305101.ch11"},{"key":"3387_CR188","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-chembioeng-060816-101514","volume":"8","author":"MR Prausnitz","year":"2017","unstructured":"Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Annu Rev Chem Biomol Eng. 2017;8:177\u2013200. https:\/\/doi.org\/10.1146\/annurev-chembioeng-060816-101514.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"3387_CR189","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jpubeco.2016.11.010","volume":"145","author":"AD Stern","year":"2017","unstructured":"Stern AD. Innovation under regulatory uncertainty: evidence from medical technology. J Public Econ. 2017;145:181\u2013200. https:\/\/doi.org\/10.1016\/j.jpubeco.2016.11.010.","journal-title":"J Public Econ"},{"key":"3387_CR190","doi-asserted-by":"publisher","first-page":"e40658","DOI":"10.1016\/j.heliyon.2024.e40658","volume":"10","author":"A Cammarano","year":"2024","unstructured":"Cammarano A, Iacono SD, Battisti M, De Stefano L, Meglio C, Nicolais L. A systematic review of microneedles technology in drug delivery through a bibliometric and patent overview. Heliyon. 2024;10:e40658. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40658.","journal-title":"Heliyon"},{"key":"3387_CR191","doi-asserted-by":"publisher","DOI":"10.1007\/s10961-022-09980-8","author":"S Kwon","year":"2022","unstructured":"Kwon S, Youtie J, Porter A, Newman N. How does regulatory uncertainty shape the innovation process? Evidence from the case of nanomedicine. J Technol Transf. 2022. https:\/\/doi.org\/10.1007\/s10961-022-09980-8.","journal-title":"J Technol Transf"},{"key":"3387_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/micronano.2016.49","author":"H Takahashi","year":"2016","unstructured":"Takahashi H, Jung Heo Y, Arakawa N, Kan T, Matsumoto K, Kawano R, Shimoyama I. Scalable fabrication of microneedle arrays via spatially controlled UV exposure. Microsyst Nanoeng. 2016. https:\/\/doi.org\/10.1038\/micronano.2016.49.","journal-title":"Microsyst Nanoeng"},{"key":"3387_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/fmedt.2024.1461460","author":"M Mochizuki","year":"2024","unstructured":"Mochizuki M, Maeda H. Trends in the market for drug delivery devices categorized as combination drugs and medical devices and regulatory challenges for autoinjectors in Japan. Front Med Technol. 2024. https:\/\/doi.org\/10.3389\/fmedt.2024.1461460.","journal-title":"Front Med Technol"},{"key":"3387_CR194","doi-asserted-by":"publisher","unstructured":"Rimpi, Verma SJ, Pinky, Baldi A. Evidence-based recommendations for comprehensive regulatory guidelines in medical devices: the imperative for global harmonization. Naunyn-Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-03843-3.","DOI":"10.1007\/s00210-025-03843-3"},{"key":"3387_CR195","doi-asserted-by":"publisher","unstructured":"Ezike TC, Okpala US, Onoja UL, Nwike PC, Ezeako EC, Okpara JO, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9:e17488\u2013e17488. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17488.","DOI":"10.1016\/j.heliyon.2023.e17488"},{"key":"3387_CR196","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/hpm.3671","volume":"38","author":"F Albuquerque","year":"2023","unstructured":"Albuquerque F, Ricardo M. Different regulatory framework for medical devices and drugs in the European Union: impact on clinical research and health technology assessments. Int J Health Plann Manage. 2023;38:1420\u201334. https:\/\/doi.org\/10.1002\/hpm.3671.","journal-title":"Int J Health Plann Manage"},{"key":"3387_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120491","volume":"267","author":"RSJ Ingrole","year":"2021","unstructured":"Ingrole RSJ, Azizoglu E, Dul M, Birchall JC, Gill HS, Prausnitz MR. Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity. Biomaterials. 2021;267: 120491. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120491.","journal-title":"Biomaterials"},{"key":"3387_CR198","doi-asserted-by":"publisher","unstructured":"Suryabhan DR, Balasaheb AS. Microneedles for transdermal drug delivery: a systematic review. Int J Pharm Sci Nanotechnol. 2022;15:5868\u201374. https:\/\/doi.org\/10.37285\/ijpsn.2022.15.2.6.","DOI":"10.37285\/ijpsn.2022.15.2.6"},{"key":"3387_CR199","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ipha.2023.09.008","volume":"2","author":"D Kumar C","year":"2024","unstructured":"Kumar C D, Goudanavar PS, Gsn KR, Kumar MP, G B KK, Ramesh B, Naveen NR. Microneedle technology- an insight into advancements, latest scholarly and patent data. Intelligent Pharmacy. 2024;2:114\u201321. https:\/\/doi.org\/10.1016\/j.ipha.2023.09.008.","journal-title":"Intelligent Pharmacy"},{"key":"3387_CR200","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1872211309666150313155503","volume":"9","author":"M Lhernould","year":"2015","unstructured":"Lhernould M, Tailler S, Deleers M, Delchambre A. Review of patents for microneedle application devices allowing fluid injections through the skin. Recent Pat Drug Delivery Formulation. 2015;9:146\u201357. https:\/\/doi.org\/10.2174\/1872211309666150313155503.","journal-title":"Recent Pat Drug Delivery Formulation"},{"key":"3387_CR201","doi-asserted-by":"publisher","unstructured":"Chen Y, Cong Y. Domestic technology review of microneedle patents. International Conference on Modern Medicine and Global Health (ICMMGH 2023). 2023. p. 126. https:\/\/doi.org\/10.1117\/12.3000296.","DOI":"10.1117\/12.3000296"},{"key":"3387_CR202","doi-asserted-by":"publisher","unstructured":"Piao H, Choi Y, Kim JH, Park DS, Lee J, Khang DY, et al. Impedance-based polymer microneedle patch sensor for continuous interstitial fluid glucose monitoring. Biosens Bioelectron. 2024;247:115932\u2013115932. https:\/\/doi.org\/10.1016\/j.bios.2023.115932.","DOI":"10.1016\/j.bios.2023.115932"},{"key":"3387_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116697","volume":"265","author":"G Zhong","year":"2024","unstructured":"Zhong G, Liu Q, Wang Q, Qiu H, Li H, Xu T. Fully integrated microneedle biosensor array for wearable multiplexed fitness biomarkers monitoring. Biosens Bioelectron. 2024;265: 116697. https:\/\/doi.org\/10.1016\/j.bios.2024.116697.","journal-title":"Biosens Bioelectron"},{"key":"3387_CR204","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/mi16080929","volume":"16","author":"K Haider","year":"2025","unstructured":"Haider K, Dalton C. Recent developments in microneedle biosensors for biomedical and agricultural applications. Micromachines. 2025;16:929\u2013929. https:\/\/doi.org\/10.3390\/mi16080929.","journal-title":"Micromachines"},{"key":"3387_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091491","volume":"10","author":"S Vijayanand","year":"2022","unstructured":"Vijayanand S, Patil S, Joshi D, Menon I, Gomes KB, Kale A, Bagwe P, Yacoub S, Uddin MN, D\u2019Souza MJ. Microneedle delivery of an adjuvanted microparticulate vaccine induces high antibody levels in mice vaccinated against coronavirus. Vaccines. 2022;10: 1491. https:\/\/doi.org\/10.3390\/vaccines10091491.","journal-title":"Vaccines"},{"key":"3387_CR206","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3762\/bjnano.14.70","volume":"14","author":"RD Baker-Sediako","year":"2023","unstructured":"Baker-Sediako RD, Richter B, Blaicher M, Thiel M, Hermatschweiler M. Industrial perspectives for personalized microneedles. Beilstein J Nanotechnol. 2023;14:857\u201364. https:\/\/doi.org\/10.3762\/bjnano.14.70.","journal-title":"Beilstein J Nanotechnol"},{"key":"3387_CR207","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ijbiomac.2020.12.177","volume":"170","author":"N Dabholkar","year":"2021","unstructured":"Dabholkar N, Gorantla S, Waghule T, Rapalli VK, Kothuru A, Goel S, Singhvi G. Biodegradable microneedles fabricated with carbohydrates and proteins: revolutionary approach for transdermal drug delivery. Int J Biol Macromol. 2021;170:602\u201321. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.177.","journal-title":"Int J Biol Macromol"},{"key":"3387_CR208","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1021\/acs.biomac.2c00878","volume":"23","author":"Z Ye","year":"2022","unstructured":"Ye Z, Xiang Y, Monroe T, Yu S, Dong P, Xian S, Webber MJ. Polymeric microneedle arrays with glucose-sensing dynamic-covalent bonding for insulin delivery. Biomacromol. 2022;23:4401\u201311. https:\/\/doi.org\/10.1021\/acs.biomac.2c00878.","journal-title":"Biomacromol"},{"key":"3387_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116793","volume":"278","author":"X Chen","year":"2024","unstructured":"Chen X, Dou X, Qiu W. Promising strategies for smart insulin delivery system: glucose-sensitive microneedle. Eur J Med Chem. 2024;278: 116793. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116793.","journal-title":"Eur J Med Chem"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03387-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03387-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:51:51Z","timestamp":1780390311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03387-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":209,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3387"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03387-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"160"}}